Clinical trial
Sevoflurane's Effect on Neurocognition Study
NCT06044740 is registered in ClinicalTrials.gov with Keith M Vogt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sevoflurane's Effect on Neurocognition Study
- Lead sponsor
- Keith M Vogt
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 17, 2024
- Completion date
- January 30, 2026
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.